###begin article-title 0
Real-Time Imaging of HIF-1alpha Stabilization and Degradation
###end article-title 0
###begin p 1
Conceived and designed the experiments: EM RB IS. Performed the experiments: EM SC KD SB IS. Analyzed the data: EM SC HTT RB IS. Wrote the paper: EM RB IS.
###end p 1
###begin p 2
###xml 998 999 958 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1380 1383 1332 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 1447 1449 1387 1389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,</sub>
###xml 1584 1587 1524 1527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 1776 1784 1700 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1789 1796 1713 1720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
HIF-1alpha is overexpressed in many human cancers compared to normal tissues due to the interaction of a multiplicity of factors and pathways that reflect specific genetic alterations and extracellular stimuli. We developed two HIF-1alpha chimeric reporter systems, HIF-1alpha/FLuc and HIF-1alpha(DeltaODDD)/FLuc, to investigate the tightly controlled level of HIF-1alpha protein in normal (NIH3T3 and HEK293) and glioma (U87) cells. These reporter systems provided an opportunity to investigate the degradation of HIF-1alpha in different cell lines, both in culture and in xenografts. Using immunofluorescence microscopy, we observed different patterns of subcellular localization of HIF-1alpha/FLuc fusion protein between normal cells and cancer cells; similar differences were observed for HIF-1alpha in non-transduced, wild-type cells. A dynamic cytoplasmic-nuclear exchange of the fusion protein and HIF-1alpha was observed in NIH3T3 and HEK293 cells under different conditions (normoxia, CoCl2 treatment and hypoxia). In contrast, U87 cells showed a more persistent nuclear localization pattern that was less affected by different growing conditions. Employing a kinetic model for protein degradation, we were able to distinguish two components of HIF-1alpha/FLuc protein degradation and quantify the half-life of HIF-1alpha fusion proteins. The rapid clearance component (t1/2 approximately4-6 min) was abolished by the hypoxia-mimetic CoCl2, MG132 treatment and deletion of ODD domain, and reflects the oxygen/VHL-dependent degradation pathway. The slow clearance component (t1/2 approximately200 min) is consistent with other unidentified non-oxygen/VHL-dependent degradation pathways. Overall, the continuous bioluminescence readout of HIF-1alpha/FLuc stabilization in vitro and in vivo will facilitate the development and validation of therapeutics that affect the stability and accumulation of HIF-1alpha.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Feldser1">[1]</xref>
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Krishnamachary1">[2]</xref>
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Pugh1">[3]</xref>
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Semenza1">[4]</xref>
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Chen1">[5]</xref>
###xml 249 252 249 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Seagroves1">[6]</xref>
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Semenza2">[7]</xref>
###xml 394 395 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 444 447 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Semenza3">[8]</xref>
###xml 449 452 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Laughner1">[9]</xref>
###xml 875 879 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kaelin1">[10]</xref>
###xml 881 885 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Jaakkola1">[11]</xref>
###xml 887 891 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Jeong1">[12]</xref>
###xml 1096 1100 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Groulx1">[13]</xref>
###xml 1305 1309 1271 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kallio1">[14]</xref>
###xml 1311 1315 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Bruick1">[15]</xref>
###xml 1372 1373 1334 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1490 1494 1452 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Neckers1">[16]</xref>
###xml 1496 1500 1458 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Whitesell1">[17]</xref>
###xml 1610 1614 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Liu1">[18]</xref>
The HIF-1 (hypoxia inducible transcriptional factor 1) controls the expression of genes involved in critical aspects of cancer biology, such as angiogenesis, glucose metabolism, cell survival, invasion and tumor progression [1], [2], [3], [4], [5], [6], [7]. HIF-1 is a heterodimeric protein complex composed of two subunits: a stable and constitutively expressed HIF-1beta, and an inducible, O2- and growth factor-regulated HIF-1alpha-subunit [8], [9]. HIF-1alpha protein is constantly modified posttranslationally by prolyl hydroxylases at Pro402 and/or Pro564 within the oxygen-dependent degradation (ODD) domain which promotes binding with pVHL (von Hippel-Lindau protein) and subsequent targeting for rapid proteasomal degradation. The half-life of HIF-1alpha protein, as determined by standard immunoblotting method, is about 5-8 min under normal oxygenated conditions [10], [11], [12]. It has been proposed, that interaction between pVHL and HIF-1alpha occurs in the nucleus, where HIF-1alpha protein is ubiquitinated and then exported to the cytoplasm for further proteasomal degradation [13]. Under hypoxic conditions, the prolyl hydroxylation reaction is inhibited and pVHL-HIF-1alpha interaction is abrogated, resulting in HIF-1alpha accumulation in the nucleus and dimerization with HIF-1beta [14], [15]. The degradation of HIF-1alpha is also regulated in an O2-independent manner by the competitive binding to either heat shock protein 90 (HSP90), which stabilizes the protein [16], [17], or to the anchoring protein (RACK1), which leads to HIF-1alpha degradation by an oxygen-independent process [18].
###end p 4
###begin p 5
###xml 77 81 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Zhong1">[19]</xref>
###xml 83 87 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Talks1">[20]</xref>
###xml 311 315 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Zhong2">[21]</xref>
###xml 474 483 470 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL, PTEN</italic>
###xml 488 491 484 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 618 621 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Laughner1">[9]</xref>
###xml 623 627 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Zhong2">[21]</xref>
###xml 629 633 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kaper1">[22]</xref>
###xml 635 639 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Li1">[23]</xref>
###xml 641 645 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Pore1">[24]</xref>
###xml 36 41 <span type="species:ncbi:9606">human</span>
HIF-1alpha is overexpressed in many human cancers compared to normal tissues [19], [20], and this overexpression is due to the interaction of a multiplicity of factors and pathways that reflect specific genetic alterations and extracellular stimuli (e.g., hypoxia) that impact on both synthesis and degradation [21]. The activation of oncogenes (H-ras and v-src) involving signaling cascades (PI3K and MAPK), as well as loss of function mutations in tumor suppressor genes (VHL, PTEN and p53), have also been shown to result in HIF-1alpha protein accumulation and increased expression of downstream HIF-1 target genes [9], [21], [22], [23], [24].
###end p 5
###begin p 6
###xml 204 214 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;</italic>
###xml 234 252 226 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firefly luciferase</italic>
###xml 254 258 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLuc</italic>
###xml 498 499 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The objective of this study was to investigate and compare the tightly controlled level of HIF-1alpha protein in normal and tumor cells by imaging the dynamic response of different fusion variants of the HIF-1alpha gene linked to the Firefly luciferase (FLuc) gene. To accomplish this goal, we engineered several different reporter constructs and generated reporter cell lines to study the dynamic stability of HIF-1alpha under hypoxia and in the presence of a prolyl hydroxylation inhibitor - CoCl2, a protein synthesis inhibitor - cycloheximide, and a proteasomal degradation inhibitor - MG132. Using immunofluorescence microscopy, we observed different patterns of subcellular localization of HIF-1alpha/FLuc fusion protein between normal cells and cancer cells; similar differences were observed for HIF-1alpha in non-transduced, wild-type cells. By employing a kinetic model for protein degradation, we were able to quantify the half-life of HIF-1alpha/FLuc noninvasively in cells with different genetic backgrounds using a more sensitive dynamic bioluminescence imaging technique.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Generation of reporter vectors
###end title 8
###begin p 9
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Ponomarev1">[25]</xref>
###xml 356 357 356 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 357 364 357 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 357 364 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1A</bold></xref>
###xml 364 370 364 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (1)).</bold>
###xml 418 429 418 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLuciferase</italic>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP (</italic>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Che1">[26]</xref>
###xml 670 671 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 671 678 659 666 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 671 678 659 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1A</bold></xref>
###xml 678 687 666 675 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (2, 3)).</bold>
All DNA manipulations were performed using restriction enzymes, T4 DNA ligase, CIP, and buffers according to standard procedures and manufacturer's instructions (Life Technologies, Inc., Roche and New England BioLabs, CA, USA). The initial retroviral vector SFG-FLuc-IRES2-GFP was developed through several steps using SFG-TK/GFP plasmid as a backbone [25](Fig. 1A (1)). This vector contained constitutively expressed FLuciferase and GFP (green fluorescent protein) separated by an internal ribosome entry site (IRES2) [26]. Based on this plasmid, two additional retroviral vectors were developed: SFG-HIF-1alpha/FLuc-IRES2-GFP, SFG-HIF-1alpha(DeltaODDD)/Fluc-IRES2-GFP (Fig. 1A (2, 3)).
###end p 9
###begin title 10
A. Structure of the reporter systems and development of the reporter cells.
###end title 10
###begin p 11
###xml 280 313 276 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945; and Firefly Luciferase</italic>
###xml 401 411 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;</italic>
###xml 483 494 471 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLuciferase</italic>
###xml 783 784 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The retroviral plasmid with constitutively expressed Firefly Luicferase and GFP (1) was used as the backbone plasmid for developing the HIF-1alpha reporter systems and served as a control vector for Firefly Luciferase. Vector (2) contains a fusion between the full length cDNA of HIF-1alpha and Firefly Luciferase genes in a bicistronic cassette with IRES2-GFP. Vector (3) contains the fusion gene of HIF-1alpha with a deleted oxygen-dependent degradation domain (ODDD) sequence and FLuciferase in a bicistronic cassette with IRES2-GFP. B,C. Bioluminescence imaging of HIF-1alpha/Fluc accumulation in NIH3T3 reporter cells. Temporal changes in bioluminescence from HIF-1alpha/FLuc expression (B) and HIF-1alpha(DeltaODDD)/Fluc expression (C) in NIH3T3 cells after treatment with CoCl2 (100 microM). Note the log-order difference in bioluminescence intensity (ordinate scale) between panels (B) and (C). NIH3T3 cells lysates were used for Western blotting with antibodies to HIF-1alpha to identify the HIF-1alpha/FLuc fusion protein and endogenous HIF-1alpha in the same cells.
###end p 11
###begin p 12
###xml 225 228 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 248 300 232 284 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTCTTCCATGGATGCGGCTGCCTTTGCGGCTGCTTCCTTTGCGGCTGC</named-content>
###xml 462 466 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Arai1">[27]</xref>
###xml 468 506 448 486 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCATCCTCTAGAATGGAGGGCGCCGGCGGCGCGA</named-content>
###xml 508 560 488 540 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGGCGGCTTCTGCAAGGTTAACTTGATCCAAAGCTCTGAGTAATTCTTC</named-content>
###xml 562 615 542 595 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGCTTCTTTCGCTGCGGCCCTCTTTTGCGGCGGCTTCTGCAAGGTTAAC</named-content>
###xml 615 667 595 647 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCTGCTTCCTTTGCGGCTGCTTCCTTGGCTGCAGCTTCTTTCGCTGCG</named-content>
###xml 708 711 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 713 716 693 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 844 859 820 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;/FLuc</italic>
###xml 883 886 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
To construct the SFG-HIF-1alpha/FLuc-IRES2-GFP vector, cDNA for HIF-1alpha was amplified from pCEP4-HIF-1alpha (ATCC, VA, USA) by 4 step PCR amplification with one primer for the 5' end of HIF-1alpha cDNA that incorporated a NcoI restriction site: 5'-CGTCTTCCATGGATGCGGCTGCCTTTGCGGCTGCTTCCTTTGCGGCTGC and four consecutive primers for elongation of the PCR amplified fragment, and by introducing a sequence encoding for 30 amino acid linker downstream HIF-1alpha [27]: 5'-ACCATCCTCTAGAATGGAGGGCGCCGGCGGCGCGA, 5'-CGGCGGCTTCTGCAAGGTTAACTTGATCCAAAGCTCTGAGTAATTCTTC, 5'-CAGCTTCTTTCGCTGCGGCCCTCTTTTGCGGCGGCTTCTGCAAGGTTAAC5'-GGCTGCTTCCTTTGCGGCTGCTTCCTTGGCTGCAGCTTCTTTCGCTGCG. The resulting PCR product was used for NcoI/XbaI ligation into the SFG-FLuc-IRES2-GFP backbone to obtain the final plasmid SFG-HIF-1alpha/FLuc-IRES2-GFP where the fusion gene HIF-1alpha/FLuc was separated from the GFP by an IRES element.
###end p 12
###begin p 13
###xml 15 30 15 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;/FLuc</italic>
###xml 438 465 418 445 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAAGAAAAGTCTCGAGATGCAGC</named-content>
###xml 467 497 447 477 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATAGTTTAGCGGCCGCAGCAAAGTTAA</named-content>
###xml 499 529 479 509 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATAGAAGCGGCCGCAGACTCAAATAC</named-content>
###xml 531 557 511 537 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCGGATCCTTACACGGCGATCT</named-content>
###xml 577 580 557 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 582 585 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 591 594 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 596 599 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 669 672 645 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 678 681 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 706 717 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;(</italic>
###xml 722 732 690 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ODDD)/FLuc</italic>
To construct a HIF-1alpha/FLuc fusion gene with a deleted oxygen-dependent degradation domain (DeltaODDD), corresponding to 1206-1813 bp in the HIF-1alpha ORF and 401-603 amino acids the HIF-1alpha protein, the following approach was used. PCR primers, corresponding to the N-terminal and C-terminal ends of the HIF-1alpha protein and two additional primers corresponding to the internal part of protein without ODD domain were designed: 5'-AAAAGAAAAGTCTCGAGATGCAGC, 5'-ATAGTTTAGCGGCCGCAGCAAAGTTAA, 5'-CATAGAAGCGGCCGCAGACTCAAATAC, 5'-GGCGGATCCTTACACGGCGATCT. PCR products with XhoI/NotI and NotI/BamHI ends were subcloned into the SFG-HIF-1alpha/Fluc-IRES2-GFP between XhoI and BamHI sites to generate the HIF-1alpha(DeltaODDD)/FLuc fusion gene without the ODDD sequence.
###end p 13
###begin p 14
###xml 203 207 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Serganova1">[28]</xref>
SFG-FLuc-IRES2-GFP, SFG-HIF-1alpha/FLuc-IRES2-GFP, SFG-HIF-1alpha(DeltaODDD)/Fluc-IRES2-GFP retroviral plasmids were transfected into a GPG293 producer cell line using LipofectAMINE 2000 (Invitrogen, CA)[28] according to the manufacturer's protocol. The retrovirus-containing medium was collected over four consecutive days and stored at -80degreesC.
###end p 14
###begin title 15
Cells transduction
###end title 15
###begin p 16
###xml 370 377 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s001">Fig. S1</xref>
###xml 369 377 369 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(<xref ref-type="supplementary-material" rid="pone.0005077.s001">Fig. S1</xref></bold>
All cell lines were stably transduced by incubating 50% confluent cell cultures with a virus-containing medium for 12 hours in presence of polybrene (8 mg/ml; Sigma, St.Louis, MO, USA). Cells were sorted using the fluorescence-activated cell sorter (FACS; BD Bioscience, CA, USA) with identical gates to obtain populations of cells with the same GFP fluorescence level (Fig. S1).
###end p 16
###begin title 17
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro bioluminescence assays
###end title 17
###begin p 18
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 251 252 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 569 570 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 973 974 963 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
Stably transduced and sorted cells were seeded in 6-well plates. The medium was changed 24 h later with fresh medium containing CoCl2 (100 microM) (Sigma-Aldrich, St. Louis, MO, USA). Alternatively cells were incubated under hypoxic conditions (2.5% O2) during 3, 6, 8 and 24 h in a HERA cell 150 chamber (Thermo Electron Corporation, USA). The cells were collected in PBS with 10% FCS, counted with a disposable hemocytometer (Incyto, SKC Co., Republic of Korea), and assessed for viability by trypan blue staining. Bioluminescence assays were always performed on 2x104 cells in 96-well plates using 10 microl of Bright-Glo Luciferase solution (Promega Cor., Madison, WI, USA). An IVIS(R) Imaging System 200 (Caliper Life Sciences, CA) and Photon imager (Biospace, Paris, France) were used to measure FLuciferase activity. The acquisition time was dependent on the signal intensity in the different reporter cell lines. All measurements are reported as photons/second/2x104 cells, folds or % of FLuciferase activity.
###end p 18
###begin title 19
Protein degradation assay and half-life calculation
###end title 19
###begin p 20
###xml 278 279 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 322 323 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 928 929 920 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 939 940 927 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 948 949 936 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 959 960 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 965 966 949 950 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 976 977 956 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sub>
###xml 1030 1033 1010 1013 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
Cells were seeded into 96-well plates. After 3-4 hours of incubation in standard conditions, the protein synthesis inhibitor cycloheximide (100 microg/ml) (Sigma-Aldrich, St. Louis, MO, USA) was added for the indicated periods of time to the medium. In the experiments with CoCl2 treatment, cells were pretreated with CoCl2 for 3 h which was either maintained in the medium during cycloheximide exposure or was removed before exposure to cycloheximide. Following incubation, the cells were assayed for bioluminescence using Bright-Glo Luciferase solution. FLuciferase activity of the test cells was normalized to that of untreated control cells and expressed as % of control. The times profiles for FLuciferase activity were generated and fitted to either a single or double exponential equation to estimate the degradation rate of FLuicferase activity (reflecting the amount of HIF-1alpha/FLuc fusion protein): % of control = A0.ewedge(-ka.t) or A0.ewedge(-ka.t)+B0.ewedge(-kb.t), respectively. The half-life was calculated by: t1/2 = ln2/k. Data fitting was performed using KaleidaGraph (Synergy Software version 3.6.4).
###end p 20
###begin title 21
Western blotting
###end title 21
###begin p 22
###xml 673 684 <span type="species:ncbi:3704">horseradish</span>
Cell lines underwent protein extraction using Mammalian Protein Extraction Reagent (Pierce, Rockford, IL, USA) or SDS sample buffer (62.5 mM Tris-HCl/pH 6.8, 2% w/v SDS, 10% Glycerol, 50 mM DTT). Protein concentrations were determined by Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA). The proteins in equivalent amounts (10-40 microg/well) were separated by electrophoresis in a NuPAGE gradient 4-12% Bis-Tris Gel (Invitrogen, Carlsbad, CA, USA) and were immuno-blotted with anti-HIF-1alpha (RD Systems, Minneapolis, MN, USA) at a 1:200 dilution, and anti-ss-actin ( Abcam Inc., Cambridge, MA, USA ) at a 1:5,000 dilution antibodies. Immune complexes were detected by horseradish-peroxidase-labeled antibodies and enhanced chemiluminescence reagent (Amersham, Buckinghamshire, UK).
###end p 22
###begin title 23
Immunofluorescence microscopy
###end title 23
###begin p 24
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
###xml 575 579 <span type="species:ncbi:9925">goat</span>
###xml 585 590 <span type="species:ncbi:10090">mouse</span>
Adherent cells were fixed with 4% paraformaldehyde in PBS for 12 min, washed three times with PBS, permeabilized with 0.2% Triton X-100 in Superblock (Pierce, Rockford, Il) for 30 min and washed again with PBS (at room temperature). After blocking nonspecific binding with ImageIT (Molecular Probes, Carlsbad, CA) for 30 min at room temperature, the cells were incubated with mouse anti-HIF-1alpha (BD Biosciences, San Jose, CA and RD Systems, Minneapolis, MN, USA) at 1:50 dilution in Superblock overnight at 4degreesC. Primary antibodies were detected by incubation with a goat anti-mouse secondary antibody conjugated to Alexa-568 (Molecular Probes Carlsbad, CA) diluted in Superblock at 1:100, at room temperature for 1 h. Following washing in PBS, cells were mounted in Vectashield (Burlingame, CA) containing 1.5 mg/ml DAPI. Fluorescence images were acquired at x40 magnification using an Olympus BX40 fluorescence microscope (Olympus America, Inc.) with CCD camera. DAPI, GFP and HIF-1alpha were imaged using blue, green and red filters respectively.
###end p 24
###begin title 25
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo bioluminescence imaging
###end title 25
###begin p 26
###xml 199 200 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 279 284 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nu/nu</italic>
###xml 779 780 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 285 294 <span type="species:ncbi:10090">nude mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">Mice</span>
The animal protocol was approved by the Memorial Sloan-Kettering Institutional Animal Care and Use Committee. The U87/HIF-1alpha/Fluc, U87/HIF-1alpha(DeltaODDD)/Fluc and U87/Fluc reporter cells (4x106) were injected subcutaneously onto the right shoulder of 6-weeks old male Ncr nu/nu nude mice. After 1 week of tumor growth, a size of the xenografts reached a diameter of approximately6-7 mm. For the FLuciferase substrate delivery into mice, the micro-osmotic pumps (Alzet Model 1007D) (Durect Corporation, CA, USA), loaded with D-Luciferin (50 mg/ml) (Caliper Life Sciences, CA, USA), were surgically implanted in the dorsal back subcutaneously. Mice were allowed to recover for 48 h and than imaged using IVIS imaging system before and after intraperitoneal injection of CoCl2 (60 mg/kg). Photons emitted from the tumor region were quantified using Living Image software (Caliper Life Sciences, CA).
###end p 26
###begin title 27
Statistical analyzes
###end title 27
###begin p 28
###xml 246 247 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Each experiment or assay was performed at least three times in triplicate and representative examples are shown. Data are reported as means+/-SD, applying Dunnett's ANOVA-based multiple comparisons procedure for comparing several treatments (CoCl2 and hypoxia) with a single control and separately for each reporter. P<0.05 is considered significant.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Development of reporter cells
###end title 30
###begin p 31
###xml 125 126 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 151 161 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;</italic>
###xml 164 171 156 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 164 171 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1A</bold></xref>
###xml 171 175 163 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (2)</bold>
###xml 205 217 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945; (</italic>
###xml 222 227 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ODDD)</italic>
###xml 280 287 264 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 280 287 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1A</bold></xref>
###xml 287 291 271 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (3)</bold>
###xml 313 331 297 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firefly Luciferase</italic>
###xml 382 386 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Arai1">[27]</xref>
###xml 388 392 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP,</italic>
###xml 581 588 565 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s001">Fig. S1</xref>
###xml 581 588 565 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0005077.s001">Fig. S1</xref></bold>
###xml 612 617 <span type="species:ncbi:10090">mouse</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
###xml 939 944 <span type="species:ncbi:9606">human</span>
Three new retroviral vectors were developed to study the regulation of HIF-1alpha accumulation/degradation processes in cells. Fusion genes containing HIF-1alpha ( Fig. 1A (2)), or a mutant variant of the HIF-1alpha (DeltaODDD) with a deleted oxygen-dependent degradation domain (Fig. 1A (3)), were linked to the Firefly Luciferase by a rationally designed linker of 30 amino acids [27]. GFP, separated by an IRES2 element in the fusion gene cassettes, was used to FACS-sort GFP-positive transduced cells in order to obtain populations of cells with similar GFP expression levels (Fig. S1). NIH3T3 (immortalized mouse fibroblasts) and U87 (human glioblastoma) cells were stably transduced with these reporter vectors. The reporter cell lines included: NIH3T3/HIF1alpha/FLuc, U87/HIF1alpha/FLuc, as well as NIH3T3/HIF-1alpha(DeltaODDD)/Fluc, U87/HIF-1alpha(DeltaODDD)/Fluc, and control NIH3T3/FLuc, and U87/FLuc. We also transduced HEK293 (human embryonic kidney) cells with the SGF-HIF1alpha/FLuc-IRES2-GFP reporter system.
###end p 31
###begin title 32
Bioluminescence imaging of HIF-1alpha levels in cells
###end title 32
###begin p 33
###xml 318 319 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 357 367 341 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B, C</bold>
###xml 357 367 341 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1B, C</bold></xref>
###xml 685 692 657 664 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 685 692 657 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1B</bold></xref>
###xml 881 888 845 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 881 888 845 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g001"><bold>Fig. 1C</bold></xref>
To characterize the reporter systems, we performed several experiments to show the functionality of the HIF1alpha/FLuc and HIF-1alpha(DeltaODDD)/FLuc fusion proteins in NIH3T3 reporter cells. Bioluminescence intensity was measured following the addition of an inhibitor of prolyl hydroxylation, a hypoxia mimetic, CoCl2 (100 microM), to the culture medium (Fig. 1B, C). An increase of HIF-1alpha/FLuc expression was detectable within the first several hours, reaching a maximum value within 3-8 h, followed by a return toward basal levels following 24 h of treatment. These data were confirmed by Western blotting for the fusion HIF-1alpha/FLuc and for endogenous HIF-1alpha proteins (Fig. 1B). In the case of reporter cells bearing the HIF-1alpha(DeltaODDD)/FLuc fusion, we did not see any significant changes in bioluminescence signal over 24 h as well as in the fusion protein (Fig. 1C).
###end p 33
###begin title 34
Imaging HIF-1alpha levels in different cell lines
###end title 34
###begin p 35
###xml 171 178 159 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 171 178 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2A</bold></xref>
###xml 400 407 384 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 400 407 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2A</bold></xref>
###xml 474 475 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 551 558 519 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 551 558 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2A</bold></xref>
###xml 585 586 553 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 616 617 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 908 909 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 946 947 886 887 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 947 954 887 894 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 947 954 887 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2A</bold></xref>
###xml 1133 1134 1069 1070 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1144 1145 1080 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1160 1167 1092 1099 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 1160 1167 1092 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2C</bold></xref>
###xml 1167 1168 1099 1100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
The HIF-1alpha/FLuc and HIF-1alpha(DeltaODDD)/Fluc fusion proteins expression in NIH3T3 fibroblasts was compared to that obtained in reporter-transduced U87 glioma cells (Fig. 2A). The HIF1alpha/FLuc basal expression under normoxia, as measured by bioluminescence intensity, was approximately 9.5-fold higher (p = 0.006) in reporter-transduced U87 cells than in the reporter-transduced NIH3T3 cells (Fig. 2A). Exposing the NIH3T3 reporter-transduced cells to 100 microM CoCl2 resulted in a approximately15-fold increase (p<0.0001) in bioluminescence (Fig. 2A). Moderate hypoxia (2.5% O2) was less effective than CoCl2 in these cells, but still resulted in a statistically significant 6-fold increase (p<0.0001) in bioluminescence signal intensity. The U87/HIF1alpha/FLuc cells demonstrated a approximately10-fold (p<0.0001) and approximately2-fold (p = 0.0016) increase in bioluminescence in response to CoCl2 treatment and hypoxia, respectively (Fig. 2A). The HEK293/HIF1alpha/FLuc reporter cells as well showed low normoxic baseline levels of bioluminescence and an increase in bioluminescence following exposure to hypoxia (2.5% O2) and CoCl2 (100 microM) (Fig. 2C).
###end p 35
###begin title 36
Comparison of HIF-1alpha/Fluc levels in NIH3T3, HEK293 and U87 cell lines.
###end title 36
###begin p 37
###xml 104 105 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 161 162 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 476 477 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 533 534 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
A comparison of HIF-1alpha/FLuc and HIF-1alpha(DeltaODDD)/Fluc bioluminescence after treatment with CoCl2 (100 microM) and under low oxygen concentration (2.5% O2) for 6 h in NIH3T3 and U87 reporter cells. *: p<0.01 vs. the control. **: p<0.0001 vs. the control (A). The level of the expression HIF-1alpha/FLuc reporter and endogenous HIF-1alpha in reporter cells under the same conditions (B). Bioluminescence imaging of HEK293/HIF-1alpha/Fluc cells after treatment with CoCl2 (100 microM) and under low oxygen concentration (2.5% O2) for 6 h (C).
###end p 37
###begin p 38
###xml 184 191 176 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 184 191 176 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2A</bold></xref>
###xml 922 923 858 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 936 943 872 879 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 936 943 872 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2A</bold></xref>
We also measured bioluminescence of cells transduced with a mutant-variant of HIF-1alpha, containing a deleted oxygen-dependent degradation domain (DeltaODDD) in the fusion construct (Fig. 2A). As expected, bioluminescence activity from NIH3T3 and U87 HIF-1alpha(DeltaODDD)/Fluc reporter cells under baseline normoxic conditions was much higher than that in cells transduced with the HIF-1alpha/Fluc fusion. The bioluminescence signal from the NIH3T3/HIF-1alpha(DeltaODDD)/Fluc reporter cells under normoxia was approximately300-fold greater (p<0.0001) than that of HIF-1alpha/Fluc transduced cells. A similar comparison of U87 reporter cells demonstrated a approximately50-fold increase (p = 0.0002) in bioluminescence signal as a result of ODDD deletion. The expression levels of the mutated HIF-1alpha(DeltaODDD)/Fluc reporter in NIH3T3 and U87 cells were similar to each other and not influenced by treatment with CoCl2 or hypoxia (Fig. 2A).
###end p 38
###begin p 39
###xml 110 111 106 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 308 309 300 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 328 329 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 436 443 428 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 436 443 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g002"><bold>Fig. 2B</bold></xref>
To examine whether the increase in bioluminescence was due to HIF-1alpha stabilization or to an effect of CoCl2 on the FLuc reporter, the same experiments were performed using cells constitutively expressing Firefly Luciferase. FLuc bioluminescence intensity was not influenced by exposure to 100 microM CoCl2 or hypoxia (2.5% O2) (data not shown). All bioluminescence data were confirmed by Western blotting using specific antibodies (Fig. 2B).
###end p 39
###begin title 40
The analysis of HIF-1alpha distribution in cells by immunofluorescence microscopy
###end title 40
###begin p 41
###xml 607 614 591 598 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 607 614 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003"><bold>Fig. 3A</bold></xref>
###xml 614 615 598 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 658 665 638 645 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 658 665 638 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>Fig. 4A</bold></xref>
###xml 804 811 784 791 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3C</bold>
###xml 804 811 784 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003"><bold>Fig. 3C</bold></xref>
###xml 811 813 791 793 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 813 815 793 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4C</bold>
###xml 813 815 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>4C</bold></xref>
###xml 881 888 857 864 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B</bold>
###xml 881 888 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003"><bold>Fig. 3B</bold></xref>
###xml 916 923 888 895 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B</bold>
###xml 916 923 888 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>Fig. 4B</bold></xref>
###xml 1020 1021 992 993 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1269 1270 1233 1234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1270 1277 1234 1241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 1270 1277 1234 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003"><bold>Fig. 3A</bold></xref>
###xml 1277 1279 1241 1243 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 1279 1281 1243 1245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</bold>
###xml 1279 1281 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>4A</bold></xref>
###xml 1281 1283 1245 1247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 1448 1449 1404 1405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1460 1461 1416 1417 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1461 1472 1417 1428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B, 3C</bold>
###xml 1461 1472 1417 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003"><bold>Fig. 3B, 3C</bold></xref>
###xml 1472 1474 1428 1430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 1474 1480 1430 1436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4B, 4C</bold>
###xml 1474 1480 1430 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>4B, 4C</bold></xref>
###xml 1480 1481 1436 1437 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1644 1645 1592 1593 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1648 1655 1596 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s002">Fig. S2</xref>
###xml 1657 1659 1605 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>
###xml 1661 1663 1609 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s004">S4</xref>
###xml 1647 1664 1595 1612 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(<xref ref-type="supplementary-material" rid="pone.0005077.s002">Fig. S2</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s004">S4</xref>)</bold>
###xml 1876 1877 1820 1821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1886 1887 1830 1831 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1967 1968 1903 1904 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1968 1974 1904 1910 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5</bold>
###xml 1968 1974 1904 1910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g005"><bold>Fig. 5</bold></xref>
###xml 1979 1986 1915 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s002">Fig. S2</xref>
###xml 1988 1990 1924 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>
###xml 1974 1992 1910 1928 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and <xref ref-type="supplementary-material" rid="pone.0005077.s002">Fig. S2</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>).</bold>
Having characterized the behavior of the reporter proteins in the stably transduced cell lines, we sought to investigate whether the different genetic backgrounds of the cells influenced the intracellular localization of HIF-1alpha and its fusion proteins. To show that endogenous HIF-1alpha protein possess the same cytoplasmic-nuclear trafficking patterns as the HIF-1alpha/FLuc reporter, we also performed immunofluorescence staining of non-transduced, wild-type NIH3T3, U87 and HEK293 cells. As seen by immunofluorescence microscopy under normoxia HIF-1alpha/FLuc localization in NIH3T3 reporter cells (Fig. 3A) and HIF-1alpha in wild-type NIH3T3 cells (Fig. 4A) was primarily cytoplasmic, compared to the more equal distribution between nucleus and cytoplasm in HEK293 reporter and wild-type cells (Fig. 3C, 4C). In contrast, more intense nuclear staining of HIF-1alpha/FLuc (Fig. 3B) and wild-type HIF-1alpha (Fig. 4B) was observed in U87 reporter and non-transduced cells, respectively. Following exposure to CoCl2 there was a consistent shift in HIF-1alpha/FLuc and HIF-1alpha localization to the nucleus in all three cell lines. NIH3T3 reporter and wild-type cells showed increased accumulation in both compartments, with more intense cytoplasmic accumulation (Fig. 3A, 4A). In contrast, U87 and HEK293 reporter-transduced and wild-type cells showed much greater accumulation of HIF-1alpha/FLuc and HIF-1alpha in the nucleus following CoCl2 treatment (Fig. 3B, 3C, 4B, 4C). The same pattern of the HIF-1alpha/FLuc and HIF-1alpha re-distribution was observed after exposure of all three reporter-transduced cell lines to hypoxia (2.5% O2) (Fig. S2, S3, S4). Interestingly, the deletion of the oxygen-dependent degradation domain from HIF-1alpha resulted in a predominant nuclear accumulation of the mutant fusion protein under normal growth conditions, hypoxia (2.5% O2) or CoCl2 treatment, for both NIH3T3 and U87 HIF-1alpha(DeltaODDD)-transduced cell lines (Fig. 5 and Fig. S2, S3).
###end p 41
###begin title 42
Immunofluorescence analysis of HIF-1alpha/Fluc trafficking in reporter NIH3T3, HEK293 and U87 cell lines.
###end title 42
###begin p 43
###xml 179 180 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 283 246 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
The NIH3T3/HIF-1alpha/Fluc (A), U87/HIF-1alpha/Fluc (B) and HEK293/HIF-1alpha/Fluc (C) reporter-transduced cells were cultured under normoxic conditions or in the presence of CoCl2 (100 microM) for 6 h. Cells were prepared for immunofluorescence as described in Materials and Methods and were incubated with the anti-HIF-1alpha antibody followed by an Alexa-568-conjugated secondary antibody. Cells were also visualized for GFP expression. Fluorescence images were acquired using the same acquisition parameters at x40 magnification. All panels represent the magnified images after contrast and brightness adjustment to visualize the subcellular localization of the protein.
###end p 43
###begin title 44
Immunofluorescence analysis of endogenous HIF-1alpha trafficking in wild-type NIH3T3, HEK293 and U87 cell lines.
###end title 44
###begin p 45
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 219 240 215 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
The non-transduced wild-type NIH3T3 (A), U87 (B) and HEK293 (C) cells were cultured under normoxic conditions or in the presence of CoCl2 (100 microM) for 6 h. Cells were prepared for immunofluorescence as described in Materials and Methods and were incubated with the anti-HIF-1alpha antibody followed by an Alexa-568-conjugated secondary antibody. Cells were also visualized for GFP expression. Fluorescence images were acquired using the same acquisition parameters at x40 magnification. All panels represent the magnified images after contrast and brightness adjustment to visualize the subcellular localization of the protein.
###end p 45
###begin title 46
Immunofluorescence analysis of HIF-1alpha(DeltaODDD)/Fluc trafficking in NIH3T3 and U87 reporter cell lines.
###end title 46
###begin p 47
###xml 161 162 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 271 279 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003">Figure 3</xref>
NIH3T3/HIF-1alpha(DeltaODDD)/Fluc and U87/HIF-1alpha(DeltaODDD)/Fluc reporter-transduced cells were cultured under normoxic conditions or in the presence of CoCl2 (100 microM) for 6 h. Cells were prepared for immunofluorescence and analyzed as described in the legend to Figure 3.
###end p 47
###begin p 48
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 159 160 159 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 160 166 160 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3</bold>
###xml 160 166 160 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003"><bold>Fig. 3</bold></xref>
###xml 166 168 166 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</bold>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>4</bold></xref>
###xml 169 171 169 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 171 172 171 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</bold>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g005"><bold>5</bold></xref>
###xml 177 184 177 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s002">Fig. S2</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s004">S4</xref>
###xml 172 194 172 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and <xref ref-type="supplementary-material" rid="pone.0005077.s002">Fig. S2</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s004">S4</xref>).</bold>
###xml 230 238 230 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 230 238 230 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g004"><bold>Figure 4</bold></xref>
###xml 243 253 243 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s002">Figures S2</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005077.s004">S4</xref>
###xml 238 261 238 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and <xref ref-type="supplementary-material" rid="pone.0005077.s002">Figures S2</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s003">S3</xref>, <xref ref-type="supplementary-material" rid="pone.0005077.s004">S4</xref></bold>
###xml 486 487 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
GFP fluorescence, the identifier of reporter-transduced cells, remained unchanged under normoxia, hypoxia or CoCl2 treatment and served as an internal control (Fig. 3, 4, 5 and Fig. S2, S3, S4). Furthermore, the data presented in Figure 4 and Figures S2, S3, S4 clearly demonstrate that the subcellular distribution of the endogenous HIF-1alpha in wild-type cells is the same as the HIF-1alpha/FLuc fusion protein in reporter-transduced cells under normal basal growing conditions, CoCl2 treatment or hypoxia (2.5%).
###end p 48
###begin title 49
Real-time imaging of HIF-1alpha stabilization in tumor xenografts
###end title 49
###begin p 50
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 140 141 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 471 472 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 702 703 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 777 787 741 751 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A, B</bold>
###xml 777 787 741 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g006"><bold>Fig. 6A, B</bold></xref>
###xml 855 856 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
To characterize the reporter systems in vivo, a series of experiments were performed to image the stabilization of HIF-1alpha following CoCl2 administration and inhibition of prolyl hydroxylases in animals bearing a HIF-1alpha/FLuc reporter xenograft. Three sets of mice bearing one of three constitutively expressing reporter xenografts were studied: HIF-1alpha/FLuc, HIF-1alpha(DeltaODDD)/FLuc and FLuciferase (control). After a single intraperitoneal injection of CoCl2 (60 mg/kg), a time-dependent increase in tumor bioluminescence was observed in U87/HIF-1alpha/FLuc xenografts. The maximum bioluminescence intensity, approximately6-fold over pretreatment values, was observed 40-90 min after CoCl2 administration. The signal decreased gradually to basal levels over 5 h (Fig. 6A, B). In contrast, only a slight increase in bioluminescence after CoCl2 injection was detected in mice bearing the U87/HIF-1alpha(DeltaODDD)/FLuc or U87/Fluc control xenografts.
###end p 50
###begin title 51
###xml 57 64 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Bioluminescence imaging of HIF-1alpha/FLuc stabilization in vivo.
###end title 51
###begin p 52
###xml 199 200 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 480 481 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 527 528 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Bioluminescence imaging of HIF-1alpha/FLuc stabilization in U87/HIF-1alpha/FLuc xenograft-bearing animals was performed at the indicated time points before and after intraperitoneal injection of CoCl2 (60 mg/kg). D-luciferin was delivered by an implanted micro-osmotic pump (A). Graph represents temporal changes in bioluminescence of U87/HIF-1alpha/Fluc (solid circle), U87/HIF-1alpha(DeltaODDD)/Fluc (grey square), U87/FLuc-IRES-GFP (solid triangle) xenografts treated with CoCl2. Data is normalized to the baseline (pre-CoCl2) value (B).
###end p 52
###begin title 53
Assessment of HIF-1alpha/FLuc and HIF-1alpha(DeltaODDD)/FLuc degradation in different cell lines
###end title 53
###begin p 54
###xml 402 408 382 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7</bold>
###xml 402 408 382 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7</bold></xref>
###xml 408 411 388 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 411 412 391 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</bold>
###xml 411 412 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g008"><bold>8</bold></xref>
###xml 603 606 579 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 632 635 608 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 684 691 648 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 684 691 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7A</bold></xref>
###xml 691 694 655 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 694 696 658 660 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8A</bold>
###xml 694 696 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g008"><bold>8A</bold></xref>
###xml 696 697 660 661 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 697 705 661 669 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tables 1</bold>
###xml 697 705 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t001"><bold>Tables 1</bold></xref>
###xml 705 708 669 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 708 709 672 673 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 708 709 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t002"><bold>2</bold></xref>
###xml 813 820 773 780 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8C</bold>
###xml 813 820 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g008"><bold>Fig. 8C</bold></xref>
###xml 904 907 864 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 1102 1105 1042 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 1267 1274 1195 1202 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 1267 1274 1195 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7A</bold></xref>
###xml 1274 1277 1202 1205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 1277 1279 1205 1207 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8A</bold>
###xml 1277 1279 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g008"><bold>8A</bold></xref>
###xml 1279 1280 1207 1208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 1280 1288 1208 1216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tables 1</bold>
###xml 1280 1288 1208 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t001"><bold>Tables 1</bold></xref>
###xml 1288 1291 1216 1219 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 1291 1292 1219 1220 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 1291 1292 1219 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t002"><bold>2</bold></xref>
To assess pVHL-ODDD-dependent degradation of HIF-1alpha/FLuc in NIH3T3 and U87 reporter cells, the time-course and the degradation rate of the fusion proteins (HIF-1alpha/FLuc and HIF-1alpha(DeltaODDD)/FLuc), as well as FLuc alone was determined by sequential bioluminescence measurements following the addition of a protein synthesis inhibitor (cycloheximide, 100 microg/ml) to the incubation medium (Fig. 7and8). Degradation of the HIF-1alpha/FLuc fusion protein in reporter-transduced NIH3T3 and U87 cells under normoxic conditions had a bi-exponential clearance, readily separated into rapid (mean t1/2 4-6 min) and slow (mean t1/2 approximately200 min) kinetic phase components (Fig. 7Aand8A;Tables 1and2). A similar bi-exponential clearance profile of HIF-1alpha/FLuc was observed in HEK293 reporter cells (Fig. 8C). In contrast, only a single exponential, reflecting a slow clearance phase (mean t1/2 approximately160 min) was identified in both NIH3T3 and U87 cells transduced with the HIF-1alpha(DeltaODDD)/FLuc fusion construct. Similarly, only a single, very slow clearance component (mean t1/2 approximately400 min) was identified for the constitutively expressed, native FLuc protein under normoxic conditions in NIH3T3/FLuc and U87/FLuc reporter cells (Fig. 7Aand8A;Tables 1and2).
###end p 54
###begin title 55
Assessment of HIF-1alpha/FLuc degradation in NIH3T3 cells under different conditions.
###end title 55
###begin p 56
###xml 626 627 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 883 891 855 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g003">Figure 3</xref>
The degradation rate of the reporter proteins (HIF-1alpha/FLuc, HIF-1alpha(DeltaODDD)/FLuc and FLuc) was determined by sequential bioluminescence measurements following addition of a protein synthesis inhibitor (CHX 100 microg/ml) to the medium. The data were fitted to either a single or double exponential equation to estimate the protein degradation rate (half-life). The graphic plots and fitted curves are representative experiments (A and B); NIH3T3 cells lysates were used for immunoblotting with antibodies to HIF-1alpha to assess HIF-1alpha/FLuc fusion protein and endogenous HIF-1alpha protein degradation after CoCl2 - containing media was removed and replaced with CHX containing media for 0, 7 and 90 min (C). Under the same conditions as that described for panel (C), the cells were analyzed by fluorescence imaging using the same procedure, described in the legend to Figure 3.
###end p 56
###begin title 57
Assessment of HIF-1alpha/FLuc degradation in U87 and HEK293 cells under different conditions.
###end title 57
###begin p 58
The degradation rate of the reporter proteins (HIF-1alpha/FLuc, HIF-1alpha(DeltaODDD)/FLuc and FLuc) was determined by sequential bioluminescence measurements following addition of a protein synthesis inhibitor (CHX,100 microg/ml) to the medium. The data were fitted to either a single or double exponential equation to estimate the protein degradation rate (half-life). The graphic plots show a representative set of experiments (A, B and C).
###end p 58
###begin title 59
Determination of HIF-1alpha/FLuc half-life in NIH3T3 cells.
###end title 59
###begin p 60
The mean HIF-1alpha/FLuc, HIF-1alpha(DeltaODDD)/FLuc and FLuc protein half-lives were calculated based on 3-6 independent experiments.
###end p 60
###begin p 61
###xml 4 5 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
CoCl2 was removed from medium before CHX addition; NF- not found.
###end p 61
###begin title 62
Determination of HIF-1alpha/FLuc half-life in U87 cells.
###end title 62
###begin p 63
The mean HIF-1alpha/FLuc, HIF-1alpha(DeltaODDD)/FLuc and FLuc protein half-lives was calculated based on 3-6 independent experiments.
###end p 63
###begin p 64
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 177 184 165 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7B</bold>
###xml 177 184 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7B</bold></xref>
###xml 184 185 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 185 192 173 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 185 192 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t001"><bold>Table 1</bold></xref>
###xml 225 232 209 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8B</bold>
###xml 225 232 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g008"><bold>Fig. 8B</bold></xref>
###xml 232 233 216 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 233 240 217 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 233 240 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t002"><bold>Table 2</bold></xref>
###xml 391 392 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 504 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Demidenko1">[29]</xref>
###xml 564 568 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Brugarolas1">[30]</xref>
###xml 570 574 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kong1">[31]</xref>
###xml 745 746 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 811 818 775 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7B</bold>
###xml 811 818 775 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7B</bold></xref>
###xml 818 819 782 783 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 819 826 783 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 819 826 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t002"><bold>Table 2</bold></xref>
###xml 975 982 935 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7C</bold>
###xml 975 982 935 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7C</bold></xref>
###xml 1569 1576 1505 1512 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 1569 1576 1505 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7A</bold></xref>
###xml 1576 1579 1512 1515 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 1579 1581 1515 1517 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8A</bold>
###xml 1579 1581 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g008"><bold>8A</bold></xref>
###xml 1581 1582 1517 1518 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 1582 1590 1518 1526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tables 1</bold>
###xml 1582 1590 1518 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t001"><bold>Tables 1</bold></xref>
###xml 1590 1593 1526 1529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 1593 1594 1529 1530 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 1593 1594 1529 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005077-t002"><bold>2</bold></xref>
The presence of CoCl2 (100 microM) together with cycloheximide (100 microg/ml) in the medium resulted in a loss of the rapid clearance component in both NIH3T3/HIF-1alpha/FLuc (Fig. 7B;Table 1) and U87/HIF-1alpha/FLuc cells (Fig. 8B;Table 2). The clearance profile could be described by a single exponential with a mean half-time of approximately50 min after a 3 h or a 24 h exposure to CoCl2. The precise mechanism for regulating the HIF-1alpha levels is still not clear; both increased degradation [29] and decreased production of the protein have been proposed [30], [31]. Reappearance of the bi-exponential clearance of the HIF-1alpha/FLuc fusion protein, reflecting rapid and slow degradative phase, was again observed after removal of CoCl2 from the incubation medium in NIH3T3 reporter-transduced cells (Fig. 7B;Table 2). The presence of residual, non-degraded HIF-1alpha/FLuc protein after 90 min of protein synthesis inhibition was demonstrated by Western blotting (Fig. 7C), and comparable levels and rates of degradation were observed by immunoblot for endogenous HIF-1alpha and HIF-1alpha/FLuc. Thus, partial degradation of the fusion protein with a persistence of a functional Firefly luciferase component is unlikely. To demonstrate involvement of the proteasome in the degradation of the HIF-1alpha, cell lines bearing the HIF-1alpha/FLuc reporter cells were pretreated with a proteasome inhibitor, MG132 (10 microM for 3 h), followed by the addition of cycloheximide to the medium. MG132 prevented HIF-1alpha/FLuc protein degradation in all cell lines (Fig. 7Aand8A;Tables 1and2).
###end p 64
###begin p 65
###xml 238 239 230 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 239 246 231 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7D</bold>
###xml 239 246 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7D</bold></xref>
###xml 289 290 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 751 752 731 732 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 752 759 732 739 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7D</bold>
###xml 752 759 732 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7D</bold></xref>
###xml 1007 1008 983 984 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1008 1015 984 991 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7D</bold>
###xml 1008 1015 984 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005077-g007"><bold>Fig. 7D</bold></xref>
To determine if the observed rapid and slow clearance components reflect different rates of cytoplasmic and nuclear HIF-1alpha/FLuc protein degradation, NIH3T3/HIF-1alpha/FLuc reporter cells were analyzed by immunofluorescence microscopy (Fig. 7D). Reporter cells were pretreated with CoCl2 for 3 h, followed by its removal from the media and the addition of cycloheximide for 0, 7 and 90 min. HIF-1alpha/FLuc distribution within cells at 7 min after addition of cycloheximide showed slightly more nuclear intensity and a few cells visualized by DAPI staining and GFP expression were not visualized by anti-HIF-1alpha fluorescent antibody. By 90 minutes, approximately half the reporter cells were not visualized by anti-HIF-1alpha immunofluorescence (Fig. 7D), suggesting that some cells clear the HIF-1alpha/FLuc fusion protein more rapidly then other cells. GFP immunofluorescence remained unchanged under cycloheximide treatment and was used as an internal control to identify reporter-transduced cells (Fig. 7D).
###end p 65
###begin title 66
Discussion
###end title 66
###begin p 67
###xml 535 539 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Harada1">[32]</xref>
###xml 541 545 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Harada2">[33]</xref>
###xml 547 551 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Viola1">[34]</xref>
###xml 721 725 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Safran1">[35]</xref>
###xml 790 791 778 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1101 1105 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Hudson1">[36]</xref>
###xml 1107 1111 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Zundel1">[37]</xref>
###xml 1414 1418 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Katschinski1">[38]</xref>
###xml 555 560 <span type="species:ncbi:10090">mouse</span>
The two HIF-1alpha chimeric reporter systems that were developed in this study provide an opportunity to investigate HIF-1alpha stabilization/degradation process in different cell lines, both in culture and in xenografts. Several groups have studied and employed the fusion between the HIF-1alpha-ODD domain and Firefly Luciferase. The resulting fusion protein (ODD-Luc) is responsive to hypoxia and hypoxia mimetics in live cells and can be used for imaging HIF-1 oxygen/VHL-regulated activity in real-time under different conditions [32], [33], [34]. A mouse that ubiquitously expresses the ODD-Luc reporter has been successfully used to study the action of small molecule inhibitors of HIF prolyl hydroxylase activity [35]. However, the ODD-Luc reporter is useful only for studying the O2-ODD-VHL-dependent mechanism of regulating HIF-1alpha expression. HIF-1alpha protein levels are also regulated by oxygen-independent mechanisms that reflect genetic alterations in signaling pathways or regulatory factors, and result in constitutive high levels of HIF-1alpha and HIF-1 transcriptional activity [36], [37]. Two PAS domains, A and B, of the HIF-1alpha subunit in the N-terminal region frequently mediate protein-protein interactions. One or both of the HIF-1alpha PAS domains have been functionally implicated in heterodimer formation, nuclear translocation and HIF-1alpha stabilization via HSP90 association [38]. The C-terminal part of the HIF-1 alpha is involved in protein transactivation. That is why the presence of the entire length of HIF-1alpha in reporter protein is essential for understanding HIF-1alpha biology and regulation of HIF-1alpha stability, since this occurs at multiple levels and involves more than the ODD domain.
###end p 67
###begin p 68
###xml 1052 1056 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Robey1">[39]</xref>
###xml 1237 1241 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Robey1">[39]</xref>
###xml 1401 1402 1365 1366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1470 1471 1434 1435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
A comparison between HIF-1alpha/Fluc and HIF-1alpha(DeltaODDD)/Fluc expression levels, as measured by BLI, demonstrated important differences between non-tumorigenic NIH3T3 and HEK293 reporter cells and tumorigenic PTEN-defective U87 reporter cells. Non-tumorigenic NIH3T3 and HEK293 cells had low basal normoxic levels of the HIF-1alpha/FLuc expression that were readily detectable by BLI, but not by immunoblotting. The higher sensitivity of the bioluminescence reporter in comparison to the immunoblot readout in living cells provides the ability to detect low basal levels of HIF-1alpha expression without exposing cells to hypoxia or hypoxia-mimetics agents. In contrast, U87 reporter cells had high basal levels of HIF-1alpha/FLuc expression. Similar results have been shown for other cancer cells lines using an immunoblotting assessment of endogenous HIF-1alpha. For example, HIF-1alpha overexpression under standard growth conditions was detected by immunoblot in metastatic breast cancer MDA-MB-231 cells and DU145 prostate cancer cell lines [39]. Interestingly, other cells (including MCF-7, HT-29 colon, MiaPaCa pancreatic, A549 lung, and BX-PC3 prostate cancer cells) do not show measurable HIF-1alpha levels under normoxia [39]. In addition, our reporter systems demonstrated that various cell lines responded differently to inhibition of a prolyl hydroxylases, either by hypoxia or CoCl2. The reporter-transduced U87 cells showed a weaker response to CoCl2 and hypoxia, relative to normoxic baseline values, when compared to that observed in NIH3T3 reporter-transduced cells.
###end p 68
###begin p 69
###xml 312 316 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Safran1">[35]</xref>
###xml 374 381 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 469 470 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Further validation of the reporter systems was obtained with NIH3T3 and U87 cells bearing a mutated HIF-1alpha(DeltaODDD)/Fluc fusion gene. Both cell lines demonstrated similar high levels of reporter expression (BLI and immunoblot), reflecting the effect of ODDD deletion on the stability of the fusion protein [35]. In addition, we demonstrated a significant BLI response in vivo when animals bearing U87/HIF-1alpha/FLuc xenografts were given an i.p injection of CoCl2, but not in animals bearing U87/HIF-1alpha(DeltaODDD)/FLuc or native FLuc expressing (control) xenografts.
###end p 69
###begin p 70
###xml 565 569 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Groulx1">[13]</xref>
###xml 571 575 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Lee1">[40]</xref>
###xml 1023 1027 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Berra1">[41]</xref>
###xml 1029 1033 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Mylonis1">[42]</xref>
###xml 1295 1299 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Groulx1">[13]</xref>
###xml 1301 1305 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kallio1">[14]</xref>
###xml 1459 1463 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Frede1">[43]</xref>
###xml 1465 1469 1421 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Liu2">[44]</xref>
###xml 1471 1475 1427 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Stolze1">[45]</xref>
###xml 1832 1833 1772 1773 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The immunofluorescence analysis of the HIF-1alpha/FLuc subcellular localization and trafficking in reporter-transduced cell lines compared well with that of endogenous HIF-1alpha in wild-type cells. However, significant differences were observed between NIH3T3, HEK293 and U87 cells. These observations suggest a difference in cytoplasm-nuclear trafficking of the HIF-1alpha and its protein fusion between normal and tumor cells. It was previously shown under normal oxygen tension that pVHL is engaged in a constitutive shuttling between the nucleus and cytoplasm [13], [40]. Furthermore, it is generally accepted that subcellular localization of the HIF-alpha subunit in mammalian cells depends on the tumor suppressor factor pVHL, which mediates ubiquitination of HIF-1alpha. However, it has not been fully established whether proteasomal degradation of HIF-1alpha occurs in the nucleus, in the cytoplasm, or if it can take place in both compartments. Prior reports are somewhat contradictory. According to some reports [41], [42] and the results of our immunofluorescence microscopic studies, the HIF-1alpha (and HIF-1alpha/FLuc) translocation to the nucleus appears to be constitutive and independent of oxygen tension, pVHL status and the presence of a functional ODD domain in HIF-1alpha [13], [14]. In many cell lines HIF-1alpha-pVHL interaction is abrogated in response to hypoxia or hypoxia-mimetic agents, and HIF-1alpha accumulates in the nucleus [43], [44], [45]. This was clearly demonstrated for the HIF-1alpha/FLuc fusion in U87 and HEK293 reporter cells, and for endogenous HIF-1alpha in U87 and HEK293 wild-type cells, and may be occurring to a lesser degree in NIH3T3 cells as well. The presence of HIF-1alpha/FLuc and HIF-1alpha in the cytoplasm and nucleus of NIH3T3 reporter and wild-type cells exposed to CoCl2 and hypoxia indicates continuous shuttling of the protein between the nucleus and the cytoplasm. We speculate that the degradation of HIF-1alpha in this cell type can take place in both compartments at different rates, possibly due to a residual hydroxylation of HIF-1alpha or to other non-oxygen-dependent process.
###end p 70
###begin p 71
###xml 675 679 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-DiCristofano1">[46]</xref>
###xml 936 940 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Zheng1">[47]</xref>
###xml 658 665 <span type="species:ncbi:9606">patient</span>
The predominant nuclear localization of HIF-1alpha/FLuc and HIF-1alpha in U87 cells under normoxic conditions indicates that these proteins are either imported or sequestered to the nucleus in U87 reporter cells to a greater extent than that in NIH3T3 cells, or that their nucleus-to-cytoplasm shuttling of HIF-1alpha is reduced in U87 compared to NIH3T3 cells. This is consistent with the 8-10 fold difference observed in bioluminescence between the two cell lines under normoxic conditions. Reduced pVHL trafficking was recently demonstrated in clear cell renal cell carcinoma, and was associated with strong nuclear localization of HIF-1alpha and shorter patient survival [46]. Although the mechanism of HIF-1alpha shuttling between nucleus and cytoplasm is poorly understood, it is becoming evident, that HIF-1alpha subcellular distribution and compartmentalization of HIF-1alpha degradation are regulated in a cell-specific manner [47] and that there are significant differences between normal cells and cancer cells. This may reflect pVHL malfunction in cancer cells or activation of the other transduction pathways in cancer cells.
###end p 71
###begin p 72
###xml 119 123 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Zundel1">[37]</xref>
###xml 175 178 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Laughner1">[9]</xref>
###xml 179 183 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Fukuda1">[48]</xref>
###xml 219 223 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Hudson1">[36]</xref>
###xml 375 399 367 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster,</italic>
###xml 456 460 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Dekanty1">[49]</xref>
###xml 549 553 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Pore1">[24]</xref>
###xml 555 559 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Li2">[50]</xref>
###xml 375 398 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
For example, activation of the PI3K-AKT/mTOR pathway impacts on HIF-1 through an increase in HIF-1alpha protein levels [37], caused by augmentation of the protein translation [9],[48] or by stabilization of the protein [36]. In addition, it was reported that activation of the PI3K-AKT/mTOR pathway also causes a major increase in nuclear localization of HIF-alpha/Sima from Drosophila melanogaster, which is a functional homologue of mammalian HIF-1alpha [49]. U87 human glioma cells are PTEN-negative with increased PI3K-AKT/mTOR pathway activity [24], [50]. The difference in nuclear localization of HIF-alpha/Fluc and wild-type HIF-alpha in this cell line compare with a normal cells is a new observation and requires further investigation.
###end p 72
###begin p 73
Deletion of the ODDD in the HIF-1alpha/Fluc fusion protein prevents hydroxylation by prolyl-hydroxylases and abrogates HIF-1alpha(ODDD)-pVHL interaction. The HIF-1alpha(ODDD)/Fluc fusion was shown to have markedly reduced nucleus-to-cytoplasm shuttling in NIH3T3 and U87 reporter cells, and increased accumulation of the mutant fusion protein in the nucleus. This led to the generation of high bioluminescence signals from the stabilized protein in the HIF-1alpha(ODDD)/Fluc reporter cell lines. These results suggest that nuclear export plays a major role in the control of HIF-1alpha level in cells, adding a new level of complexity to the regulation of this transcriptional factor.
###end p 73
###begin p 74
###xml 348 349 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 902 906 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Huang1">[51]</xref>
###xml 908 912 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kallio2">[52]</xref>
###xml 914 918 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Salceda1">[53]</xref>
###xml 991 992 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Our immunofluorescence observations prompted us to study the dynamics of HIF-1alpha/FLuc protein degradation in greater detail. The question being addressed is whether the difference in the level of HIF-1alpha/FLuc expression under baseline normoxic conditions, as well as the ability of this fusion protein to accumulate following exposure to CoCl2 and to moderate hypoxia, is due to a difference in the pVHL-ODDD-dependent degradation process of HIF-1alpha/FLuc in different cell lines. A bi-exponential bioluminescence profile of HIF-1alpha/FLuc protein degradation was observed in NIH3T3, HEK293 and U87 reporter cells, indicating that both "rapid" and "slow" clearance mechanisms were operative. The half-time of the rapid clearance in these cells was approximately3-6 min and consistent with the currently accepted half-life of HIF-1alpha (approximately5 min) under normal non-hypoxic conditions [51], [52], [53]. Since the rapid phase HIF-1alpha/FLuc degradation was abolished by CoCl2 treatment and by deletion of the oxygen-dependent degradation domain from HIF-1alpha in NIH3T3 and U87 reporter cells, it is likely that the rapid clearance component reflects the dynamics of the oxygen-dependent pathway of HIF-1alpha degradation in these cells. A second, slow clearance component of the HIF-1alpha/FLuc degradation under normoxic conditions in these cell lines was also revealed in our kinetic analysis of the bioluminescence clearance profile. This component does not reflect degradation of native FLuc protein since immunoblots of cells taken 7, 30 and 90 min after addition of cycloheximide in the clearance studies showed the presence of both non-degraded HIF-1alpha/FLuc and non-degraded HIF-1alpha bands.
###end p 74
###begin p 75
The dynamic profile and kinetic analysis of the HIF-1alpha/FLuc degradation in NIH3T3, HEK293 and U87 cells suggests that the rapid and slow components of degradation are compartmentalized. To determine, whether the observed kinetic and anatomic compartmentalization in the cell are related, we imaged the changes in subcellular distribution during cycloheximide-induced clearance of the HIF-1alpha/FLuc protein in NIH3T3 reporter-transduced cells by immunofluorescence imaging. Some of reporter cells cleared their fluorescence (both cytoplasmic and nuclear) more quickly than others. This observation suggests that the observed kinetic compartmentalization may reflect a heterogeneity and difference in HIF-1alpha/FLuc protein degradation rate within two or more functionally different populations of NIH3T3/HIF-1alpha/FLuc cells. Despite a similar bi-phasic degradation profile of HIF-1alpha/FLuc in NIH3T3 and U87 reporter cells, the basal expression level and subcellular localization of the fusion protein in these cell lines is very different. This suggests the involvement of other regulatory mechanisms, which may account for differences in the spacial distribution and stabilization of HIF-1alpha in cells with different genetic backgrounds.
###end p 75
###begin p 76
###xml 216 219 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Semenza1">[4]</xref>
###xml 221 225 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Giaccia1">[54]</xref>
###xml 227 231 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kong2">[55]</xref>
###xml 344 348 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Kong2">[55]</xref>
###xml 489 492 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Semenza1">[4]</xref>
###xml 494 498 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Giaccia1">[54]</xref>
###xml 500 504 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Semenza4">[56]</xref>
###xml 506 510 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Yeo1">[57]</xref>
###xml 512 516 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Belozerov1">[58]</xref>
###xml 518 522 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Escuin1">[59]</xref>
###xml 524 528 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Generali1">[60]</xref>
###xml 530 534 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Powis1">[61]</xref>
###xml 536 540 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Wiedmann1">[62]</xref>
###xml 542 546 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Rapisarda1">[63]</xref>
###xml 547 551 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Mabjeesh1">[64]</xref>
###xml 553 557 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Isaacs1">[65]</xref>
###xml 559 563 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Mabjeesh2">[66]</xref>
###xml 565 569 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Rapisarda1">[63]</xref>
###xml 653 657 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Hudson1">[36]</xref>
###xml 659 663 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Majumder1">[67]</xref>
###xml 669 673 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Tan1">[68]</xref>
###xml 684 687 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Laughner1">[9]</xref>
The expression of HIF-1alpha protein is modulated through different pathways that alter HIF-1-dependent transcriptional activity and makes the HIF-1 transcription factor an attractive target for new drug development [4], [54], [55]. Several examples of HIF-1 inhibitors that target pathways associated with HIF-1 activation have been described [55]. For example, a number of anticancer drugs have been shown to inhibit HIF-1, but none of these drugs target HIF-1 directly and specifically [4], [54], [56], [57], [58], [59], [60], [61], [62], [63],[64], [65], [66], [63]. Some of these inhibitors are associated with signaling pathways that include mTOR [36], [67], AKT [68], Her2/Neu [9]. However, most inhibitors affect multiple signaling pathways and only indirectly target the HIF-1 transcription factor. Therefore, the ability to identify, visualize and validate changes in the dynamics and stability of the HIF-1alpha protein is likely to be useful as a pharmacodynamic end point and read-out of inhibition in the development of new anticancer drugs that target HIF-1alpha in the future.
###end p 76
###begin p 77
###xml 34 49 34 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF-1&#945;/FLuc</italic>
###xml 1034 1038 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Serganova1">[28]</xref>
###xml 1040 1044 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Brader1">[69]</xref>
###xml 1046 1050 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-CreightonGutteridge1">[70]</xref>
###xml 1052 1056 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Huang2">[71]</xref>
###xml 1058 1062 1042 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Yeom1">[72]</xref>
###xml 1064 1068 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005077-Harada3">[73]</xref>
###xml 1194 1202 1178 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1207 1214 1191 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In summary, the introduction of a HIF-1alpha/FLuc fusion gene into different cell lines allowed us: 1) to study the time-dependent accumulation and degradation of the fusion protein with greater sensitivity and to better quantify the rate of degradation using BLI, compared to that obtained in previous studies based on immunoblot assays; 2) to better assess the differences in subcellular localization and clearance of the fusion protein in normal and tumor cells using immunofluorescence imaging, providing spatial information to better understand HIF-1alpha trafficking and regulation in different cells; 3) to image HIF-1alpha/FLuc fusion protein stabilization and accumulation over time in animals bearing reporter-transduced xenografts. Finally, the possibility to visualize the modulation of HIF-1alpha using the chimeric reporter systems developed in the current study, in combination with transcriptional reporters based on the binding of an active HIF-1 complex to hypoxia-response elements (HRE) which drive reporter genes [28], [69], [70], [71], [72], [73], provides the opportunity to utilize them as tools for high-throughput screening of compounds affecting HIF-1 activity, both in vitro and in vivo.
###end p 77
###begin title 78
Supporting Information
###end title 78
###begin p 79
FACS analysis of reporter-transduced cells. GFP expression in developed reporter cell lines was used for FACS sorting and transduction normalization.
###end p 79
###begin p 80
(0.91 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 288 309 272 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
Immunofluorescence analysis of HIF-1alpha and its fusions expression in NIH3T3 cells. The NIH3T3/HIF-1alpha/Fluc, NIH3T3/HIF-1alpha(DeltaODDD)/Fluc and NIH3T3 non-tansduced cells were cultured under normoxia and hypoxia for 6 h. Cells were prepared for immunofluorescence as described in Materials and Methods and then were incubated with the anti-HIF-1alpha antibody followed by a Alexa-568-conjugated secondary antibody. Cells were also visualized for GFP expression. Fluorescence images were acquired at x40 magnification. All panels represent the magnified images after adjusted contrast and brightness to visualize the subcellular protein localization.
###end p 82
###begin p 83
(4.01 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 276 297 260 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
Immunofluorescence analysis of HIF-1alpha and its fusions expression in U87 cells. The U87/HIF-1alpha/Fluc, U87/HIF-1alpha(DeltaODDD)/Fluc and U87 non-tansduced cells were cultured under normoxia and hypoxia for 6 h. Cells were prepared for immunofluorescence as described in Materials and Methods and then were incubated with the anti-HIF-1alpha antibody followed by a Alexa-568-conjugated secondary antibody. Cells were also visualized for GFP expression. Fluorescence images were acquired at x40 magnification. All panels represent the magnified images after adjusted contrast and brightness to visualize the subcellular protein localization.
###end p 85
###begin p 86
(3.46 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 277 298 265 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
Immunofluorescence analysis of HIF-1alpha and HIF-1alpha/FLuc expression in HEK293 cells. The reporter-transuced HEK293/HIF-1alpha/Fluc and non-transduced HEK 293 cells were cultured under normoxia or hypoxia for 6 h. Cells were prepared for immunofluorescence as described in Materials and Methods and then were incubated with the anti-HIF-1alpha antibody followed by a Alexa-568-conjugated secondary antibody. The reporter cells were also visualized for GFP expression. Fluorescence images were acquired at x40 magnification. All panels represent the magnified images after adjusted contrast and brightness to visualize the subcellular protein localization.
###end p 88
###begin p 89
(3.10 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
We thank Dr. Neal Rosen for his invaluable help in the critical reading of this manuscript and Dr. Steven Larson (Memorial Sloan-Kettering Cancer Center) for his help and generous support. Technical services were provided by the MSKCC Small-Animal Imaging Core Facility and Flow Cytometry Facility.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
###end article-title 93
###begin article-title 94
Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.
###end article-title 94
###begin article-title 95
Regulation of angiogenesis by hypoxia: role of the HIF system.
###end article-title 95
###begin article-title 96
Targeting HIF-1 for cancer therapy.
###end article-title 96
###begin article-title 97
Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.
###end article-title 97
###begin article-title 98
Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.
###end article-title 98
###begin article-title 99
Regulation of gene expression by HIF-1.
###end article-title 99
###begin article-title 100
###xml 79 84 <span type="species:ncbi:9606">human</span>
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.
###end article-title 100
###begin article-title 101
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
###end article-title 101
###begin article-title 102
How oxygen makes its presence felt.
###end article-title 102
###begin article-title 103
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
###end article-title 103
###begin article-title 104
Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation.
###end article-title 104
###begin article-title 105
Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
###end article-title 105
###begin article-title 106
Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.
###end article-title 106
###begin article-title 107
A conserved family of prolyl-4-hydroxylases that modify HIF.
###end article-title 107
###begin article-title 108
Heat shock protein 90.
###end article-title 108
###begin article-title 109
HSP90 and the chaperoning of cancer.
###end article-title 109
###begin article-title 110
RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.
###end article-title 110
###begin article-title 111
###xml 60 65 <span type="species:ncbi:9606">human</span>
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.
###end article-title 111
###begin article-title 112
###xml 101 106 <span type="species:ncbi:9606">human</span>
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.
###end article-title 112
###begin article-title 113
###xml 143 148 <span type="species:ncbi:9606">human</span>
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
###end article-title 113
###begin article-title 114
Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
###end article-title 114
###begin article-title 115
A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.
###end article-title 115
###begin article-title 116
Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.
###end article-title 116
###begin article-title 117
###xml 27 31 <span type="species:ncbi:10298?0.9473684210526315">HSV1</span>
Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of non-invasive molecular-genetic imaging.
###end article-title 117
###begin article-title 118
hNIS-IRES-eGFP dual reporter gene imaging.
###end article-title 118
###begin article-title 119
Design of the linkers which effectively separate domains of a bifunctional fusion protein.
###end article-title 119
###begin article-title 120
###xml 144 148 <span type="species:ncbi:10090">mice</span>
Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice.
###end article-title 120
###begin article-title 121
Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.
###end article-title 121
###begin article-title 122
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
###end article-title 122
###begin article-title 123
Constitutive/Hypoxic Degradation of HIF-{alpha} Proteins by the Proteasome Is Independent of von Hippel Lindau Protein Ubiquitylation and the Transactivation Activity of the Protein.
###end article-title 123
###begin article-title 124
Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors.
###end article-title 124
###begin article-title 125
The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.
###end article-title 125
###begin article-title 126
In vivo bioluminescence imaging monitoring of hypoxia-inducible factor 1alpha, a promoter that protects cells, in response to chemotherapy.
###end article-title 126
###begin article-title 127
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production.
###end article-title 127
###begin article-title 128
Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
###end article-title 128
###begin article-title 129
Loss of PTEN facilitates HIF-1-mediated gene expression.
###end article-title 129
###begin article-title 130
Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization.
###end article-title 130
###begin article-title 131
Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors.
###end article-title 131
###begin article-title 132
Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
###end article-title 132
###begin article-title 133
Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm.
###end article-title 133
###begin article-title 134
Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha.
###end article-title 134
###begin article-title 135
The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation.
###end article-title 135
###begin article-title 136
A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression.
###end article-title 136
###begin article-title 137
###xml 52 57 <span type="species:ncbi:9606">human</span>
Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells.
###end article-title 137
###begin article-title 138
Nuclear expression of hypoxia-inducible factor-1alpha in clear cell renal cell carcinoma is involved in tumor progression.
###end article-title 138
###begin article-title 139
Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.
###end article-title 139
###begin article-title 140
Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.
###end article-title 140
###begin article-title 141
The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha/Sima.
###end article-title 141
###begin article-title 142
###xml 62 67 <span type="species:ncbi:9606">human</span>
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
###end article-title 142
###begin article-title 143
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
###end article-title 143
###begin article-title 144
Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway.
###end article-title 144
###begin article-title 145
Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.
###end article-title 145
###begin article-title 146
HIF-1 as a target for drug development.
###end article-title 146
###begin article-title 147
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
###end article-title 147
###begin article-title 148
Development of novel therapeutic strategies that target HIF-1.
###end article-title 148
###begin article-title 149
YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.
###end article-title 149
###begin article-title 150
Hypoxia inducible factor-1: a novel target for cancer therapy.
###end article-title 150
###begin article-title 151
Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.
###end article-title 151
###begin article-title 152
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
###end article-title 152
###begin article-title 153
Hypoxia inducible factor-1alpha as a cancer drug target.
###end article-title 153
###begin article-title 154
Molecularly targeted therapy for gastrointestinal cancer.
###end article-title 154
###begin article-title 155
Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
###end article-title 155
###begin article-title 156
Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.
###end article-title 156
###begin article-title 157
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.
###end article-title 157
###begin article-title 158
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
###end article-title 158
###begin article-title 159
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
###end article-title 159
###begin article-title 160
Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
###end article-title 160
###begin article-title 161
Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model.
###end article-title 161
###begin article-title 162
Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
###end article-title 162
###begin article-title 163
Short hairpin RNA interference therapy for ischemic heart disease.
###end article-title 163
###begin article-title 164
Visualization of hypoxia-inducible factor-1 transcriptional activation in C6 glioma using luciferase and sodium iodide symporter genes.
###end article-title 164
###begin article-title 165
Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals.
###end article-title 165
###begin p 166
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 166
###begin p 167
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH grants P50 CA86438-01 and PO1 CA115675. The work of SC and SB is supported in part by the Byrne Foundation. Technical services were provided by the MSKCC Small-Animal Imaging Core Facility, supported in part by NIH Small-Animal Imaging Research Program (SAIRP) grant R24 CA83084 and NIH Center grant P30 CA08748 and Flow Cytometry Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 167

